{"id":"https://openalex.org/W2133785409","doi":null,"title":"Mechanisms of negative costimulation by CTLA-4 and its manipulation in tumor immunotherapy in mice and man","display_name":"Mechanisms of negative costimulation by CTLA-4 and its manipulation in tumor immunotherapy in mice and man","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2133785409","mag":"2133785409"},"language":"en","primary_location":{"id":"mag:2133785409","doi":null,"is_oa":false,"landing_page_url":"https://cancerimmunolres.aacrjournals.org/content/canimmarch/3/Suppl_1/20.full.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764915449","display_name":"Cancer immunity","issn_l":"1424-9634","issn":["1424-9634"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer immunity","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047117233","display_name":"James Patrick Allison","orcid":"https://orcid.org/0000-0001-8980-5697","observed_orcids":["https://orcid.org/0000-0001-8980-5697","https://orcid.org/0000-0002-8949-2333"]},"institutions":[{"id":"https://openalex.org/I95457486","display_name":"University of California, Berkeley","ror":"https://ror.org/01an7q238","country_code":"US","type":"education","lineage":["https://openalex.org/I95457486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James P. Allison","raw_affiliation_strings":["University of California: Berkeley, CA#TAB#"],"raw_orcid":"https://orcid.org/0000-0001-8980-5697","affiliations":[{"raw_affiliation_string":"University of California: Berkeley, CA#TAB#","institution_ids":["https://openalex.org/I95457486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5047117233"],"corresponding_institution_ids":["https://openalex.org/I95457486"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18773353,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":null,"first_page":"20","last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.13019999861717224,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.018300000578165054,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9350000023841858},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cd28","display_name":"CD28","score":0.8989999890327454},{"id":"https://openalex.org/keywords/b7-costimulatory-molecules","display_name":"B7 costimulatory molecules","score":0.8420000076293945},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/tumor-rejection","display_name":"tumor rejection","score":0.5479999780654907},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.44999998807907104},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.718999981880188},{"id":"https://openalex.org/keywords/prophylactic-immunity","display_name":"prophylactic immunity","score":0.6589999794960022},{"id":"https://openalex.org/keywords/t-cell-synapse","display_name":"T cell synapse","score":0.5270000100135803},{"id":"https://openalex.org/keywords/protein-kinase-c","display_name":"protein kinase C","score":0.47099998593330383},{"id":"https://openalex.org/keywords/tumor-rechallenge","display_name":"tumor rechallenge","score":0.3050000071525574}],"concepts":[{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.8581483364105225},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.6296554207801819},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5818489193916321},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5635266900062561},{"id":"https://openalex.org/C9756297","wikidata":"https://www.wikidata.org/wiki/Q126223","display_name":"Immunological synapse","level":5,"score":0.5314746499061584},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.5233080387115479},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.4791354835033417},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.44614097476005554},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.44146043062210083},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4176924228668213},{"id":"https://openalex.org/C179223381","wikidata":"https://www.wikidata.org/wiki/Q419425","display_name":"Avidity","level":3,"score":0.4166225790977478},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.26842087507247925},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10471943020820618},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2133785409","doi":null,"is_oa":false,"landing_page_url":"https://cancerimmunolres.aacrjournals.org/content/canimmarch/3/Suppl_1/20.full.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764915449","display_name":"Cancer immunity","issn_l":"1424-9634","issn":["1424-9634"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer immunity","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8999999761581421,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1971422121","https://openalex.org/W2105017308","https://openalex.org/W2140460887","https://openalex.org/W2148911309"],"related_works":["https://openalex.org/W2162856391","https://openalex.org/W1971422121","https://openalex.org/W7099659819","https://openalex.org/W2116169737","https://openalex.org/W2140460887","https://openalex.org/W2059820796","https://openalex.org/W2060451389","https://openalex.org/W1522355179","https://openalex.org/W1582759408","https://openalex.org/W2048073154"],"abstract_inverted_index":{"Activation":[0],"of":[1,36,44,48,72,82,160,172,178,188,231,250,260,272,279,298,305,314,358,377,383,396,411,425,428,455,462,467,498,543,553],"naive":[2],"T":[3,40,62,164,200,457,469,473],"cells":[4,201,470,513],"is":[5,115,124,129,167,185,193,309,323,387,408,441,481,492,577],"a":[6,102,213,220,240,296,390,412,419,472,566],"complex":[7],"and":[8,52,76,91,128,180,229,340,372,500,510,528,537,550,576],"dynamic":[9,70],"process":[10],"involving":[11],"not":[12,225,451],"only":[13,226],"recognition":[14],"by":[15,33,56,277,307,325,389,446,487],"the":[16,29,34,39,45,49,61,67,73,80,119,135,163,170,173,183,227,245,263,273,337,341,381,401,409,426,429,447,453,465,483,488,496,517,548],"T-cell":[17,83,153,261,285,415],"antigen":[18,422],"receptor":[19],"(TCR)":[20],"but":[21,235],"also":[22,236],"additional":[23],"costimulatory":[24,30],"signals.":[25],"Particularly":[26],"crucial":[27],"are":[28,86,94,205,345,514,539],"signals":[31,54,78,276],"mediated":[32,55],"interaction":[35,57],"CD28":[37,75,90,114,181],"on":[38,60,66,118,244],"cell":[41,63,246,366,403,475],"with":[42,64,195,349,361,400,583],"members":[43,110],"B7":[46,65,108],"family":[47,109],"antigen-presenting":[50],"cell,":[51],"inhibitory":[53,233,274],"between":[58],"CTLA-4":[59,77,92,100,123,161,257,275,293,463,490,509,522],"APC.":[68],"The":[69,137,394,439,478],"integration":[71],"TCR,":[74],"determines":[79],"outcome":[81],"activation.":[84],"There":[85],"key":[87],"differences":[88],"in":[89,132,218,258,287,302,369,398,405,471,495,501,533,562,574,581],"that":[93,141,158,199,270,356,442,460,482,508,571],"relevant":[95,242],"to":[96,147,151,169,182,208,239,295,311,328,333,347,375,434,520],"their":[97],"functional":[98,196],"mechanisms:":[99],"has":[101],"much":[103],"higher":[104],"avidity":[105],"for":[106,256],"binding":[107],"than":[111],"does":[112,450],"CD28.":[113],"constitutively":[116],"expressed":[117],"plasma":[120],"membrane":[121],"while":[122,176],"induced":[125],"upon":[126],"activation":[127],"found":[130,157],"largely":[131,186],"vesicles":[133],"inside":[134],"cell.":[136],"latter":[138],"properties":[139,144],"suggest":[140],"its":[142,149,237],"trafficking":[143],"may":[145],"serve":[146],"restrict":[148],"ability":[150],"inhibit":[152],"responses.":[154],"We":[155,290],"have":[156,268,291,354,432,523],"accumulation":[159],"at":[162],"cell-APC":[165],"interface":[166],"proportional":[168],"strength":[171],"TCR":[174],"signal,":[175],"recruitment":[177,238],"PKC":[179],"synapse":[184],"independent":[187,476],"agonist":[189],"signal":[190,222],"strength.":[191],"This":[192,211,248,506],"consistent":[194],"data":[197],"demonstrating":[198],"receiving":[202],"stronger":[203],"stimuli":[204],"more":[206,493],"susceptible":[207],"CTLA-4-mediated":[209],"inhibition.":[210],"suggests":[212,252,507],"novel":[214],"feedback":[215],"control":[216],"mechanism":[217,249,427],"which":[219,546],"stimulatory":[221],"specifically":[223],"regulates":[224],"transcription":[228],"expression":[230],"an":[232],"receptor,":[234],"functionally":[241],"site":[243],"surface.":[247],"attenuation":[251],"previously":[253],"unrecognized":[254],"roles":[255],"regulation":[259],"responses.\n\nOver":[262],"past":[264],"several":[265],"years,":[266],"we":[267,353],"demonstrated":[269],"blockade":[271,294,461],"administration":[278,357],"anti-CTLA-4":[280,306,350,359,397],"antibodies":[281],"can":[282,373],"greatly":[283],"enhance":[284],"responses":[286],"vivo":[288],".":[289],"applied":[292],"number":[297],"experimental":[299],"tumor":[300,329,365,402,443],"systems":[301],"mice.":[303],"Administration":[304],"itself":[308],"sufficient":[310],"induce":[312],"rejection":[313,376,386,444],"many":[315],"highly":[316],"immunogenic":[317],"tumors,":[318],"including":[319,336],"well-established":[320],"tumors.":[321,379],"Rejection":[322],"accompanied":[324,388],"long-lived":[326],"immunity":[327,371],"rechallenge.":[330],"Tumors":[331],"considered":[332],"be":[334,556],"non-immunogenic,":[335],"B16":[338,384],"melanoma":[339,538],"SM1":[342],"mammary":[343],"carcinoma,":[344],"resistant":[346],"treatment":[348,491],"alone.":[351],"However,":[352],"shown":[355],"along":[360],"irradiated":[362],"GM-CSF":[363],"producing":[364],"vaccines":[367],"results":[368],"prophylactic":[370],"lead":[374],"established":[378],"In":[380],"case":[382],"melanoma,":[385],"progressive":[391],"autoimmune":[392],"depigmentation.":[393],"effect":[395],"combination":[399,430,448,489],"vaccine":[404],"this":[406],"setting":[407],"induction":[410],"potent":[413,494],"CD8+":[414,468],"response":[416,485],"directed":[417],"against":[418],"melanocyte":[420],"differentiation":[421],"TRP-2.":[423],"Studies":[424],"therapy":[431,449],"led":[433],"two":[435],"very":[436],"interesting":[437],"observations.":[438],"first":[440],"obtained":[445],"require":[452],"presence":[454],"CD4+":[456],"cells,":[458],"suggesting":[459],"allows":[464],"protection":[466],"helper":[474],"manner.":[477],"second":[479],"observation":[480],"anti-tumor":[484,518,551],"elicited":[486],"absence":[497],"CD4+,":[499],"particular":[502],"CD25+CD4+":[503],"Treg":[504,512],"cells.":[505],"CD25+":[511],"independently":[515],"regulating":[516],"response.\n\nAntibodies":[519],"human":[521],"been":[524],"produced":[525],"(Genpharm,":[526],"Inc.)":[527],"Phase":[529],"I":[530],"clinical":[531],"trials":[532],"both":[534],"prostate":[535],"cancer":[536],"underway":[540],"(Medarex).":[541],"Results":[542],"these":[544],"trials,":[545],"demonstrate":[547],"safety":[549],"activity":[552],"anti-CTLA-4,":[554],"will":[555],"discussed.":[557],"\n\nThis":[558],"abstract":[559],"was":[560],"published":[561],"Cancer":[563,584],"Immunity":[564],",":[565],"[Cancer":[567],"Research":[568,586],"Institute][1]":[569],"journal":[570],"ceased":[572],"publication":[573],"2013":[575],"now":[578],"provided":[579],"online":[580],"association":[582],"Immunology":[585],".\n\n":[587],"[1]:":[588],"http://cancerresearch.org/":[589]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}